Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study

View source ↗

Summary

A diagnostic accuracy study evaluating gastrin, Helicobacter pylori status, and pepsinogen as markers for gastric atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal College of Surgeons, Ireland | Conditions: Gastric Atrophy | Status: NOT_YET_RECRUITING